News from Asia

id-10014542

Japan approves Teijin Pharma’s Feburic

May 25, 2016  |   News

Febuxostat, currently sold in 57 countries, is expected to be made available in 117 markets in regions including North America, Europe and Asia

regular-shots-of-influenza-injections-have-the-added-benefit-of-reducing-the-risk-of-heart-attacks-in-people-in-the-40-to-64-age-group-if-they-have-narrowed-arteries

Ono, Bristol-Myers launch Orencia Auto-injector for treatment of Rheumatoid Arthritis

May 25, 2016  |   News

The manufacturing and marketing approval of Orencia Subcutaneous Injection 125 mg Auto-injector 1 mL (Orencia-AI) was obtained on February 25, 2016

drug trail

Daiichi Sankyo launches antiplatelet agent Efient in Japan

May 25, 2016  |   News

Domestically, Efient Tablets have been sold in 3.75mg/5mg dosages since May 2014

More News from Asia

Survey Box

BioSimilar Market

Can India dominate BioSimilar market?

Send this article by email

X